Mumbai: Piramal Pharma Solutions, a global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. has announced that its Grangemouth, UK facility has received updated MHRA GMP certificates following a successful compliance report and desktop inspection.

These certificates encompass all activities within the facility's Helix building, which specializes in clinical and commercial drug substance manufacture and testing. They also extend to the building's supporting warehouse and laboratory areas .

As per the release, together with the site's existing GMP certificates, the updated certificates ensure Grangemouth is well-equipped to support its clients' programs and regulatory filings.

As Piramal Pharma Solutions ' dedicated antibody-drug conj

See Full Page